AIM
RXDX

Aigen Investment Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Aigen Investment Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,672
Closed -$394K – 1027
2023
Q1 		$394K Buy
+3,672
New +$394K 0.05% 361
2022
Q4 		– Sell
-4,206
Closed -$248K – 833
2022
Q3 		$248K Buy
+4,206
New +$248K 0.04% 455